News

News Room

News
Good News | Neuboron Receives Another National Key Project Approval

2024.01.15

1847
News
China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

2024.01.09

2619
News
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

2023.12.13

5022
News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15

6846
News
Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

2023.08.14

6445
News
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

2023.05.09

7386
News
China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

2023.01.31

8025
News
In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

2022.08.30

7591
News
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

2022.03.25

7654
News
Happy 2022 and everything goes well

2021.12.31

7258
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

2021.11.10

9030
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01

8603
News
The Xiamen BNCT Center and Neuboron BNCT Group

2021.09.07

8497
News
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19

8138
News
China’s First BNCT Center Makes Debut

2021.02.09

6618

Events

News Room

Good News | Neuboron Receives Another National Key Project Approval

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

Happy 2022 and everything goes well

Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

The Xiamen BNCT Center and Neuboron BNCT Group

Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

China’s First BNCT Center Makes Debut